Estuary closed a $93 million Series A led by RA Capital Management, on top of a $10 million seed round co-led by 4BIO Capital and GV. Both seed investors joined the Series A, alongside Deep Track ...

The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...

Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma industry ...

AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...

Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...

Sponsors trialing drugs in the European Union (EU) will be able to continue seeking input from the European Medicines Agency ...

Study finds Bluesky and X users share clinical trial information differently, which could impact recruitment strategies ...

The collaboration will integrate AI more directly into scientific instrumentation, aiming to close the gap between ...

Susanne Michel, vice president, head of HTA methods and evidence planning at Clinigen, and Michael Epstein, vice president, ...

The regulatory professional then does what only they can do; apply scientific and legal judgment, validate the AI's reasoning ...

IgniteData and RealTime eClinical Solutions partner to let RealTime's clinical research sites use IgniteData's Archer ...

Axoltis’ drug, NX210c, failed to meet clinical endpoints in a Phase II trial – but the company says other readouts are ...